11 – 20 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis
(
- Contribution to journal › Article
-
Mark
Increased carotid artery lesion inflammation upon treatment with the CD137 agonistic antibody 2A
(
- Contribution to journal › Article
- 2016
-
Mark
VORTEC technique in central venous recanalization for haemodialysis access salvage.
(
- Contribution to journal › Article
-
Mark
Versican accumulates in vascular lesions in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2015
-
Mark
Perlecan heparan sulfate is required for the inhibition of smooth muscle cell proliferation by all-trans-retinoic acid
(
- Contribution to journal › Article
-
Mark
Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
(
- Contribution to journal › Article
- 2014
-
Mark
Perlecan Heparan Sulfate Proteoglycan Is a Critical Determinant of Angiogenesis in Response to Mouse Hind-Limb Ischemia
(
- Contribution to journal › Article
-
Mark
Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury
(
- Contribution to journal › Article
- 2012
-
Mark
Antenatal imatinib treatment reduces pulmonary vascular remodeling in a rat model of congenital diaphragmatic hernia
(
- Contribution to journal › Article
-
Mark
Identification of the BCAR1-CFDP1-TMEM170A Locus as a Determinant of Carotid Intima-Media Thickness and Coronary Artery Disease Risk
(
- Contribution to journal › Article